Home » Programs & Funding » Capital » Investment Applications & Guidance » Life Sciences
Investment Application

Life Sciences
Investment Application

Next proposal due date: September 5, 2012

Past proposal due date: May 2, 2012

The deadline is a firm deadline and materials are expected to be well prepared and complete at the deadline. Earlier proposal submission is welcomed.

It is strongly recommended that, at minimum, an Executive Summary and a draft of the Budget & Milestones be submitted at least 2 weeks before the proposal is due.

It is also recommended that applicant companies contact the Director of Investments for Life Sciences in advance of submitting a complete proposal, to discuss the proposal content and any questions the company may have.

Click here to view 2012 Review Cycle Dates

Overview

As BFTP/SEP seeks to invest in only the most promising early stage life sciences companies, funding is extremely competitive. Most of the companies successful in raising BFTP/SEP funding possess the following characteristics:

  • Venture experienced business management
  • Strong IP and patent protection
  • Novel and unique science
  • Sound business and scientific approach
  • Leveraged sources of capital (SBIR, Angel, Early Stage Venture Capital, other state funding sources)
  • Ability to achieve a significant milestone with BFTP/SEP dollars
  • Long term sustainability and job creation

 

Life Sciences Application Documents

  • Program Information Instructions: doc
  • Executive Summary (Due: April 18, 2012): doc
  • Application: doc
  • Budget (Due: April 18, 2012): xls
  • Milestones (Due: April 18, 2012): xls

 

Investment Levels

BFTP/SEP invests $100,000 – $500,000 as part of larger funding rounds of $200,000 – $3,000,000 involving other sources such as SBIR, Angel, Early Stage Venture Capital, and other state funding sources.

It is expected that companies funded by the Biotechnology and Life Sciences Investment vertical will achieve a significant commercial and/or technical milestone that attracts additional outside investors (Angel, Venture Capital, Government Funds), strategic partners, and/or will generate revenue.

 

Terms

BFTP/SEP’s standard investment terms for Life Science companies include:

  • Convertible Debt
  • Warrant
  • Negative Pledge (on technology)
  • Board Observation Rights
  • BFTP/SEP reporting compliance

Term Details: pdf

 

 

View LS Investment Committees

 

For more information, please contact:

MODANeat CompanyMolecular DetectionCoats AnalyticsClick EquationsClear AlignBioNano GenomicsScience CenterBio AdvanceDVIRCNFTEPennsylvania BIOPhilly Startup LeadersSELECT Greater Philadelphia